AdvaMed Applauds Senate Cloture Vote to Advance CHIPS Act
WASHINGTON – Today, the Advanced Medical Technology Association (AdvaMed), released the following statement from President and CEO Scott Whitaker on the bipartisan cloture vote to advance the CHIPS Act in the Senate:
“We are pleased to see the bipartisan Senate vote to advance the CHIPS Act today. The investments made in this bill will ensure the United States has a robust domestic manufacturing base for semiconductor chips, which is vital for medtech companies that rely on these components to develop lifesaving medical technologies that improve and save the lives of millions of patients every day. We are already witnessing the effects of ongoing supply chain disruptions within our industry, as medtech companies struggle to access the full range of semiconductor technologies they need for their products. The longer we wait to make these investments, the worse it could get for doctors and their patients. AdvaMed urges the Senate and House to pass this bipartisan bill and send it to the President’s desk to be signed into law.”